Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

BACKGROUND: Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure. METHODS: In this study, we examined the cytogenetic and tumorigenic physiognomies of distinct population o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Faizan H., Pandian, Vijayabaskar, Ramraj, Satishkumar, Natarajan, Mohan, Aravindan, Sheeja, Herman, Terence S., Aravindan, Natarajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496850/
https://www.ncbi.nlm.nih.gov/pubmed/26159519
http://dx.doi.org/10.1186/s12885-015-1463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496850/
https://www.ncbi.nlm.nih.gov/pubmed/26159519
http://dx.doi.org/10.1186/s12885-015-1463-y

Ejemplares similares